17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
Resources - Florida Supreme Court Amends Summary Judgment Procedural Rule to Mirror Federal Doctri...
Read More >
On September 10, by a vote of 29–11, the California Senate passed legislation known as AB 5 – a la...
Read More >
Editor's Overview - Happy New Year. We wrap-up 2019 with an article that reflects on significant d...
Read More >
Getting the jump on the other federal agencies, the Department of Labor (DOL) issued its final rule ...
Read More >
The Situation: The United States Department of Justice Antitrust Division ("DOJ") has provided detai...
Read More >
Seyfarth Synopsis: As detailed in our 2020 Workplace Class Action Litigation Report, 2019 was an int...
Read More >